Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02168205 · ClinicalTrials.gov registry record · Phase 1
Food Effect and CYP1A2 Induction Study in Healthy Subjects
A Phase 1 study, sponsored by Celgene.
- Completed
- Registry status
- Phase 1
- Development phase
- 55
- Enrollment target
NCT02168205 is a Phase 1 study that has completed, run by Celgene. The registered enrollment target is 55 participants.
The verdict
NCT02168205, a Phase 1 study, has completed, sponsored by Celgene.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 55 participants
- Enrollment target
Study Summary
This study will evaluate the effect of food and smoking on healthy older subjects taking pomalidomide.
Interventions
- DRUG Pomalidomide
- OTHER Caffeine
- OTHER Tobacco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 55 participants |
| Start Date | 2014-05-30 |
| Est. Completion | 2014-09-19 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02168205
The ClinicalTrials.gov registry entry for NCT02168205 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 55 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Celgene, which has 308 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Pomalidomide is the first listed.
NCT02168205 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02168205 about?
NCT02168205 is a clinical study titled "Food Effect and CYP1A2 Induction Study in Healthy Subjects". This study will evaluate the effect of food and smoking on healthy older subjects taking pomalidomide.
What is the current status of trial NCT02168205?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 55 participants. The study started on 2014-05-30. Estimated completion is 2014-09-19.
What interventions are being tested in trial NCT02168205?
The interventions under investigation include: Pomalidomide (DRUG), Caffeine (OTHER), Tobacco (OTHER).
Who is sponsoring clinical trial NCT02168205?
This trial is sponsored by Celgene, which has 308 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.